Positive prognostic impact of miR-210 in non-small cell lung cancer

被引:86
作者
Eilertsen, Marte [1 ]
Andersen, Sigve [1 ,2 ]
Al-Saad, Samer [3 ,4 ]
Richardsen, Elin [3 ,4 ]
Stenvold, Helge [1 ,2 ]
Hald, Sigurd M. [1 ]
Al-Shibli, Khalid [3 ,5 ]
Donnem, Tom [1 ,2 ]
Busund, Lill-Tove [3 ,4 ]
Bremnes, Roy M. [1 ,2 ]
机构
[1] Univ Tromso, Dept Clin Med, NO-9037 Tromso, Norway
[2] Univ Hosp North Norway, Dept Oncol, Tromso, Norway
[3] Univ Tromso, Dept Med Biol, NO-9037 Tromso, Norway
[4] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway
[5] Nordland Cent Hosp, Dept Pathol, Bodo, Norway
关键词
NSCLC; Prognosis; miR-210; Tumor stromal cells; Cancer cells; Biomarker; GENE-EXPRESSION; SQUAMOUS-CELL; HYPOXIA; TUMOR; MICRORNAS; MARKER; GROWTH; HSA-MIR-210; DIAGNOSIS; SPUTUM;
D O I
10.1016/j.lungcan.2013.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Objectives: miR-210 is an important regulator of the cellular response to hypoxia. Therefore, we aimed to explore the prognostic significance of miR-210 in non-small cell lung cancer (NSCLC) patients with stage I-IIIA disease. Materials and methods: In addition to clinicopathological and demograpic information, tumor tissues were collected and tissue micro arrays (TMAs) were constructed from 335 patients with stage I-IIIA NSCLC. Expression of miR-210 in cancer cells and stromal cells of the tumor was assessed by in situ hybridization. Results: In univariate analyses, high cancer cell (p = 0.039) and high stromal cell expression (p = 0.008) of miR-210 were both significantly associated with an improved disease-spesific survival (DSS). High co-expression of miR-210 in cancer and stromal cells was also a positive prognostic factor for DSS (p = 0.010). In multivariate analysis, miR-210 in stromal cells (p = 0.011), and miR-210 co-expressed in cancer and stromal cells was an independent prognosticator for DSS (p = 0.011). Conclusions: We show that miR-210 in stromal cells, and co-expressed in cancer cells and stromal cells mediates an independent prognostic impact. It is a candidate marker for prognostic stratification in NSCLC. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:272 / 278
页数:7
相关论文
共 44 条
[1]
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival [J].
Andersen, Sigve ;
Donnem, Tom ;
Stenvold, Helge ;
Al-Saad, Samer ;
Al-Shibli, Khalid ;
Busund, Lill-Tove ;
Bremnes, Roy M. .
PLOS ONE, 2011, 6 (08)
[2]
Andersen S, 2011, ANTICANCER RES, V31, P1603
[3]
Diverging prognostic impacts of hypoxic markers according to NSCLC histology [J].
Andersen, Sigve ;
Eilertsen, Marte ;
Donnem, Tom ;
Al-Shibli, Khalid ;
Al-Saad, Samer ;
Busund, Lill-Tove ;
Bremnes, Roy M. .
LUNG CANCER, 2011, 72 (03) :294-302
[4]
[Anonymous], CA CANC J Clin
[5]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]
MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[7]
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer [J].
Camps, Carme ;
Buffa, Francesca M. ;
Colella, Stefano ;
Moore, John ;
Sotiriou, Christos ;
Sheldon, Helen ;
Harris, Adrian L. ;
Gleadle, Jonathan M. ;
Ragoussis, Jiannis .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1340-1348
[8]
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation [J].
Cho, William C. S. ;
Chow, Andrew S. C. ;
Au, Joseph S. K. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) :2197-2206
[9]
MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress [J].
Crosby, Meredith E. ;
Kulshreshtha, Ritu ;
Ivan, Mircea ;
Glazer, Peter M. .
CANCER RESEARCH, 2009, 69 (03) :1221-1229
[10]
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells [J].
Donnem, Tom ;
Al-Saad, Samer ;
Al-Shibli, Khalid ;
Andersen, Sigve ;
Busund, Lill-Tove ;
Bremnes, Roy M. .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) :963-970